NEWS & INSIGHTS

Are you looking for new ways to get your pharma brand in front of your critical HCP targets? Consider tapping into digital opinion leaders (DOLs). “With DOLs, there’s a notable increase in interactivity and back-and-forth discussions creating a ripple effect of their influence,” says Read Roberts, PRECISIONscientia’s Director of KOL Data Solutions. Watch the latest episode of This Medical Moment as Read delves into the transformative power of DOLs in the pharma industry.

WATCH THE VIDEO HERE!

While statins have transformed cardiovascular disease prevention, patients with a lesser-known type of lipid disease called elevated lipoprotein(a) (Lp[a]) face unique challenges. Recent clinical trials exploring Lp(a)-targeting medications show promise, yet proactive screening practices vary. Cynthia Miller, MD, MPH, FACP, Vice President, Medical Director, sits down with DocWire News and shares insights on the significance of early Lp(a) screening, strategies to enhance preventative cardiology, and optimize patient care.

WATCH THE VIDEO HERE!

The Inflation Reduction Act will increase drug affordability—but that money comes from somewhere. Ryan Cox, VP, Director, PRECISIONvalue Access Experience Team, discusses the unintended consequences for payers, biopharmaceuticals—and the future of patient’s drug choices. Learn more in this video.

WATCH THE VIDEO HERE!

How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.

WATCH THE VIDEO HERE!

Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.

WATCH THE VIDEO HERE!

Patients already look beyond their prescription benefits for ways to pay. As cost-sharing rises and payer formulary controls and exclusions expand, patient demand for new solutions will grow. PRECISIONvalue Chief Medical Officer Dominic Galante discusses the future of access management in this Access90 video.

WATCH THE VIDEO HERE!

The Inflation Reduction Act will definitely impact established wholesale acquisition costs and rebates. Now that the Medicare bid season is upon us, how can manufacturers prepare? PRECISIONvalue expert Andrew Cournoyer, SVP of the Access Experience Team, explains in this must-see video.

WATCH THE VIDEO HERE!